Postoperative serum Vascular Endothelial Growth Factor is an independent prognostic factor of disease free survival and overall survival in patients with non metastatic colon cancer

M. Pascual, S. Alonso, S. Salvans, X. Mayol, S. Mojal, M. J. Gil, L. Grande, M. Pera

Research output: Contribution to journalArticleResearchpeer-review

2 Citations (Scopus)

Abstract

© 2017 Elsevier Inc. Background: Angiogenesis is essential for tumor growth and formation of metastasis. VEGF is the most potent agiogenic citokine. The aim was to investigate the predictive value of postoperative VEGF serum concentration in patients undergoing surgery for colon cancer. Methods: Consecutive patients with colon cancer undergoing surgery with curative intent were included. VEGF was measured in serum at 48 h and postoperative day 4. Cox proportional hazards model was used to estimate its contribution with prognosis. Results: A total of 94 patients were included. On multivariate analysis VEGF on postoperative day 4 (HR: 1.05; p = 0.011) was independent prognostic factor of decreased DFS and OS. Five-year DFS (57.7% vs. 85%; p = 0.001) and OS (93% vs. 72%; p = 0.005) were significantly lower in patients with postoperative serum VEGF greater than 370 pg/dl. Conclusion: Postoperative VEGF serum concentration was an independent predictor of recurrence. These results must be verified in a prospective independent testing cohort.
Original languageEnglish
Pages (from-to)255-259
JournalAmerican Journal of Surgery
Volume216
Issue number2
DOIs
Publication statusPublished - 1 Aug 2018

Keywords

  • Colon cancer
  • Prognostic factor
  • Surgery
  • Vascular Endothelial Growth Factor

Fingerprint Dive into the research topics of 'Postoperative serum Vascular Endothelial Growth Factor is an independent prognostic factor of disease free survival and overall survival in patients with non metastatic colon cancer'. Together they form a unique fingerprint.

Cite this